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Approximately 25% of US women over the age of 45 currently use statins to prevent stroke and 
heart disease. Statins are highly effective in treating hyperlipidemia, or high levels of lipids in the 
blood, a risk factor for cardiovascular disease. However, some studies have suggested that they 
may be linked to breast cancer risk. Statins have only recently begun to be used on a broad scale, 
and although multiple meta-analyses have observed no association between statins and breast 
cancer, these analyses were limited in their ability to assess the effects of long-term statin use. 
Almost all previous studies of this question were conducted in populations with a very low frequency 
of long-term statin use (less than 3% of women had used statins for 5 or more years). The potential 
association with long-term use in particular is important, as statins are generally prescribed as a 
long-term treatment. Furthermore, little is known about the association between statins and the 
specific types of breast cancer. 
Drs. Jean McDougall, Christopher Li, and colleagues in PHS addressed these questions among 
1,984 invasive breast cancer cases (including 1,068 lobular and 916 ductal cases) and 902 controls 
ages 50-74 years in the Puget Sound region. Cases and controls were interviewed to ascertain 
detailed histories of lipid-lowering drug use prior to diagnosis (or prior to a similar assigned reference 
date among controls). Extra measures were taken to maximize recall accuracy, including asking 
women to bring bottles of their medications, and to identify past medications from photos of pills and 
bottles. Participants also provided information on breast cancer risk factors and on history of 
hyperlipidemia. 
Women who reported using statins for the past 10 or more years had an 83% higher risk of invasive 
ductal breast cancer (95% confidence interval (CI) 1.1-2.9) and a doubled risk of invasive lobular 
breast cancer (95% CI 1.3-3.1) compared to women who had never used statins, after adjusting for 
age (5-year age categories), reference year, county, and use of menopausal hormone therapy. 
These associations were stronger when analyses were limited to cases and controls with 
hyperlipidemia, with a doubled risk of ductal (95% CI 1.2-3.6) and a 2.4-fold risk of lobular breast 
cancer (95% CI 1.4-4.2), compared to never-users. When analyses included all statin users (i.e. not  
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just long-term users), there was little evidence of an association, suggesting that if statins do 
increase the risk of breast cancer, they may only do so after a longer period of use. Analyses of the 
risk of specific types of breast cancer suggested that long-term statin use (10 or more years) is 
associated with a doubled risk of estrogen receptor (ER)-positive breast cancers (both ductal and 
lobular, 95% CIs 1.2-3.2 and 1.3-3.2, respectively) but not with ER-negative ductal breast cancer. 
This could be due to limited statistical power in the ER-negative ductal breast cancer analyses, or it 
may be that statins increase breast cancer via a hormonally mediated pathway. 
Dr. McDougall commented that, if future studies also observe an increased risk of invasive ductal 
and lobular breast cancers associated with long-term statin use, this would “warrant further study 
[into] the biologic mechanism by which long term statin use could impact breast cancer risk.” She 
also cited a need for additional research, in order to determine “whether the excess risk of breast 
cancer could outweigh the benefits of statins for lowering cholesterol and reducing cardiovascular 
disease risk in some women.”  
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